Matches in Wikidata for { <http://www.wikidata.org/entity/Q80621765> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q80621765 description "artículu científicu espublizáu n'agostu de 2007" @default.
- Q80621765 description "scientific article published on 17 August 2007" @default.
- Q80621765 description "wetenschappelijk artikel" @default.
- Q80621765 description "наукова стаття, опублікована в серпні 2007" @default.
- Q80621765 name "Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progression" @default.
- Q80621765 name "Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progression" @default.
- Q80621765 type Item @default.
- Q80621765 label "Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progression" @default.
- Q80621765 label "Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progression" @default.
- Q80621765 prefLabel "Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progression" @default.
- Q80621765 prefLabel "Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progression" @default.
- Q80621765 P1433 Q80621765-4DC3AC1D-EB79-412A-AAA6-45E91F1A7A8D @default.
- Q80621765 P1476 Q80621765-BA456FAB-ED80-4ECB-81B2-C02F3C824D6B @default.
- Q80621765 P2093 Q80621765-0E56117D-BE91-4E69-965A-DE01BA0894D3 @default.
- Q80621765 P2093 Q80621765-34382FA8-D620-40BB-8481-CE2BDF9126F6 @default.
- Q80621765 P2093 Q80621765-AB5FD174-3421-4E96-AE2F-8D60643A39B4 @default.
- Q80621765 P2093 Q80621765-D4C2BD43-B03B-4F0D-B3B5-6C957F7B055E @default.
- Q80621765 P304 Q80621765-10C4C3EE-F5F7-4336-9A2F-F4A825D34943 @default.
- Q80621765 P31 Q80621765-CB2DA138-DA5D-4478-92AE-36D1470B0B2F @default.
- Q80621765 P356 Q80621765-E2E51B19-422D-4879-BEFB-AB57D4E4E089 @default.
- Q80621765 P433 Q80621765-7646A2EC-C742-451A-AD9A-44354334B578 @default.
- Q80621765 P478 Q80621765-30F9C0B9-8077-4B76-A3D7-E6FF922E8BD6 @default.
- Q80621765 P50 Q80621765-3B10FEBE-91B0-4844-BD9D-DC61058CF10B @default.
- Q80621765 P50 Q80621765-7F3BEF1B-30F0-46B0-984E-3F4E5A243075 @default.
- Q80621765 P577 Q80621765-0E0C994F-007D-4192-BFEC-9E0A4F666DB5 @default.
- Q80621765 P698 Q80621765-80992D29-319C-40C2-A563-50D222F73D0C @default.
- Q80621765 P921 Q80621765-E2816F0D-653A-4E96-854E-F5927AEC197D @default.
- Q80621765 P356 CBT.6.10.4904 @default.
- Q80621765 P698 18245958 @default.
- Q80621765 P1433 Q2544651 @default.
- Q80621765 P1476 "Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progression" @default.
- Q80621765 P2093 "Douglas V Faller" @default.
- Q80621765 P2093 "Fangming Gao" @default.
- Q80621765 P2093 "Hamid Mostafavi Abdolmaleky" @default.
- Q80621765 P2093 "Hongjie Pan" @default.
- Q80621765 P304 "1638-1643" @default.
- Q80621765 P31 Q13442814 @default.
- Q80621765 P356 "10.4161/CBT.6.10.4904" @default.
- Q80621765 P433 "10" @default.
- Q80621765 P478 "6" @default.
- Q80621765 P50 Q42609448 @default.
- Q80621765 P50 Q63891040 @default.
- Q80621765 P577 "2007-08-17T00:00:00Z" @default.
- Q80621765 P698 "18245958" @default.
- Q80621765 P921 Q16909647 @default.